基本信息
浏览量:72

个人简介
Thirumurthy Velpandian is a Professor ( Pharmacology) at All India Institute of Medical Sciences, New Delhi.
His Pharmacology and Clinical Pharmacy Laboratories are involved in repurposing and developing drugs for Ocular therapeutics. His group is involved rationalizing drug therapy for various eye diseases and disorders like infections glaucoma, angiogenesis, diabetic complications etc. His group is also involved in addressing the effect of environmental pollutants on human with special reference to eye.
His laboratory is supported by grants from ICMR, DST, DBT, DRDO, BMGF, BIRAC and Other pharmaceutical and Start up companies.
His hobbies are Bio-electronics, Hindu Art and Theology and Yoga
研究兴趣
论文共 309 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Dikshit Kapil,Aafreen Bari,Namrata Sharma,Thirumurthy Velpandian,Rajesh Sinha, Prafulla Maharana,Manpreet Kaur,Tushar Agarwal
Indian journal of ophthalmologyno. Suppl 3 (2025): S428-S434
Murugesan Vanathi, Livia Khan,Thirumurthy Velpandian, Ashish Dubey,Noopur Gupta,Tulika Seth,Manoranjan Mahapatra, Maroof Ahmed Khan, Sandeep Jain,Radhika Tandon
Muskan Garg,Neha Midha,Rohit Verma,Vivek Gupta,Dewang Angmo,Thirumurthy Velpandian, Prafulla Kumar Maharana,Sujata Satapathy,Namrata Sharma,Tanuj Dada
Journal of glaucomano. 4 (2025): 282-289
Acta Ophthalmologicano. S284 (2025)
Gazella B Warjri,Lakshminarayanan Gowtham, Vatsalya Venkatraman,Thirumurthy Velpandian,Tanuj Dada,Dewang Angmo
Journal of current glaucoma practiceno. 1 (2025): 28-37
The ocular surface (2025): 47-56
Vinnyfred Vincent,Himani Thakkar,Atanu Sen, Ashutosh Bansal, Ujjalkumar Subhash Das, Abishek Gunasekaran,Neerja Bhatla,Thirumurthy Velpandian,Archna Singh
Molecular and cellular biochemistry (2025)
The Journal of membrane biology (2025)
The Indian Journal of Pediatrics (2024)
加载更多
作者统计
#Papers: 309
#Citation: 5017
H-Index: 34
G-Index: 57
Sociability: 7
Diversity: 4
Activity: 42
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn